Animal models in neurodegenerative diseases

Area of Science:

• Neuroscience
• Pathology
• Pharmacology

Background:

• Animal models are crucial for studying neurodegenerative diseases like Parkinson's disease (PD).
• Ideal models should mimic clinical manifestations and selective neuronal loss characteristic of PD.
• PD involves dopaminergic and non-dopaminergic neuronal loss, with Lewy bodies.

Purpose of the Study:

• To review and critically assess current animal models of Parkinson's disease.
• To discuss the advantages and disadvantages of different model types for neuroprotection studies.

Main Methods:

• Review of existing literature on animal models of PD.
• Categorization of models based on etiological approaches: genetic and toxin-induced.
• Evaluation of models based on their ability to reproduce PD pathophysiology and neuronal loss.

Main Results:

• Genetic models replicate inherited PD forms by introducing specific mutations.
• Toxin-induced models mimic PD by exposing animals to neurotoxic agents.
• Both approaches have limitations in fully recapitulating PD's complex pathology.

Conclusions:

• Currently available animal models offer valuable insights but have limitations for neuroprotection research.
• Careful selection of models is essential to accurately study PD pathogenesis and test therapeutic strategies.
• Further development of more comprehensive animal models is needed.